SEC Form 4 · accession 0001078782-18-000932
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Aug 23, 2018
Accepted (ET)
Aug 29, 2018 · 10:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2018 | P | 25,000 | $0.12 | A | 14,843,831 | D | |
| Common Stock | Aug 24, 2018 | P | 60,000 | $0.13 | A | 15,003,831 | D | |
| Common Stock | Aug 27, 2018 | P | 17,000 | $0.15 | A | 15,020,831 | D |
Table II — derivative securities
No Table II lines on this filing.